Overview

Safety and Effectiveness Evaluation of Two Kinds of Peritoneal Dialysate

Status:
Active, not recruiting
Trial end date:
2021-09-01
Target enrollment:
Participant gender:
Summary
This study is to evaluate the effectiveness and safety of Huaren Peritoneal Dialysate and Baxter Peritoneal Dialysate, investigate the proper dialysis dose for Chinese CAPD patients.
Phase:
Phase 4
Details
Lead Sponsor:
Chinese PLA General Hospital
Treatments:
Dialysis Solutions